版本:
中国

BRIEF-Oramed receives Israel regulatory approval

May 2 Oramed Pharmaceuticals Inc:

* Oramed receives Israel regulatory approval to conduct human study for new oral leptin capsule

* Oramed Pharmaceuticals-Israel's ministry of health approved Oramed's commencement of proof of concept single dose study for its oral leptin drug candidate Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐